Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trial.
BMJ Open. 2019 May 10;9(5):e024485
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE).
J Immunother Cancer. 2019 Mar 13;7(1):72
Optimal Ultrasonographic Measurements for Diagnosing Carpal Tunnel Syndrome in Patients With Diabetic Sensorimotor Polyneuropathy: A Case-Control Study.
Ann Rehabil Med. 2019 Feb;43(1):45-53
Anticancer drugs approved by the Food and Drug Administration for gastrointestinal malignancies: Clinical benefit and price considerations.
Cancer Med. 2019 Apr;8(4):1584-1593
Human Papillomavirus and p16 Immunostaining, Prevalence and Prognosis of Squamous Carcinoma of Unknown Primary in the Head and Neck Region.
Int J Cancer. 2019 Jan 30;:
Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.
Health Sci Rep. 2018 Jul;1(7):e48
Curr Oncol. 2018 Dec;25(6):366-370
J Geriatr Oncol. 2018 Dec 23;:
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Eur J Cancer. 2018 Dec 18;107:142-152